TRANSFERRIN - ANVISA Registration 80836930074
Access comprehensive regulatory information for TRANSFERRIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80836930074 and manufactured by VEDALAB. The registration is held by ARBO DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BECKMAN COULTER INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80836930074
25351534612201707
06203702000159
Company Information
Dates and Status
Dec 18, 2017
VIGENTE
09/18/2025 19:00:01
FERRITIN
FRT– CHECK-1
VEDALAB
80836930024
May 26, 2014
TRANSFERRIN
Access sTfR QC1
BECKMAN COULTER INC.
10033120840
Nov 25, 2013
TRANSFERRIN
TRANSFERRIN FS
DIASYS DIAGNOSTIC SYSTEMS GMBH & CO
10350840223
Nov 07, 2011
TRANSFERRIN
TRANSFERRINA TURBIQUEST
LABTEST DIAGNOSTICA S/A
10009010117
Feb 06, 2006
TRANSFERRIN
CONTROLE CDT NORMAL
SEBIA S.A.
80416660048
Jun 02, 2014
TRANSFERRINA
Transferrina
DIAGAM S.A.
81546350088
Sep 08, 2025
TRANSFERRINA
Família Transferrina
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390327
Jun 16, 2025
TRANSFERRINA
Transferrina
DIAGAM S.A.
81546350079
Jan 06, 2025
TRANSFERRINA
3diag - sTfR - OPT Kit
TRIMERO DIAGNOSTICS, S.L.
81357320141
Jan 06, 2025
TRANSFERRINA
Teste de Transferrina (Ouro coloidal)
ANHUI DEEPBLUE MEDICAL TECHNOLOGY CO., LTD.
82444370076
Nov 13, 2023